NewLink and Roche Pair Off on Cancer Immunotherapy
Insights - NewLink (NLNK) and Roche (RHHBY) will collaborate on the development of new IDO inhibitors, and combinations with NLNK's NLG919.
Read NowInsights
If You Visited Us this Week You Knew Exactly Where to Look for the Rally
Insights - In last week’s biotech recap, and again at PropThink.com this week, we outlined some key support levels for the S&P 500 (SPX or SPY), explaining … Continue Reading
Read Now
FDA Continues to Quash Interest in Repros Therapeutics
Insights - FDA put the breaks on Repros (RPRX) on Friday when it indicated that an upcoming meeting would not be the pre-NDA meeting investors expected.
Read Now
Tekmira’s Not All About Ebola: First Hepatitis B Data Encouraging
Insights - Tekmira (TKMR) revealed the first data for TKM-HBV publicly on Wednesday at a medical conference. Though early, Mr. Fink likes what he sees.
Read Now
Why 1800 (or thereabouts) for the S&P 500 is So Interesting
Insights - Multiple reasons for support, 1800 on the SPX/SPY is an interesting level to watch. No, it's not time to panic.
Read Now
Shire and AbbVie May Be Going Their Own Ways as Lawmakers Crack Down
Insights - AbbVie (ABBV) is walking back its plan to buy Shire Plc (SHPG) on concerns over new U.S. laws making it harder for American companies to lower taxes through inversions, or … Continue Reading
Read Now
First Pharma Giant to Report, J&J Posts Strong Third Quarter
Insights - Johnson & Johnson (JNJ) reported third quarter earnings on Tuesday and $18.5 billion in revenue (+5.1% over the quarter a year ago), with net earnings of $4.7 billion … Continue Reading
Read Now